Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets

v3.25.4
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Mar. 31, 2025
Current assets    
Cash, cash equivalents, and restricted cash $ 40,423 $ 40,084
Accounts receivable, net 245,324 181,770
Prepaid expenses 7,529 6,923
Value-added tax receivable 10,552 8,291
Other current assets 14,246 5,711
Total current assets 318,074 242,779
Property and equipment, net 48,984 46,966
Right-of-use assets 7,577 9,924
Intangible assets, net 226,961 257,697
Goodwill 223,788 221,741
Other non-current assets 32,791 33,747
TOTAL ASSETS 858,175 812,854
Current liabilities    
Accounts payable 127,538 139,944
Accrued revenue share 94,123 35,264
Accrued compensation 17,459 7,503
Acquisition purchase price liabilities 540 1,697
Short-term debt, net of debt discount and issuance costs 4,688 0
Other current liabilities 43,801 38,118
Total current liabilities 288,149 222,526
Long-term debt, net of debt discount and issuance costs 350,280 408,687
Derivative liabilities 4,402 0
Deferred tax liabilities, net 11,698 16,308
Other non-current liabilities 9,044 11,375
Total liabilities 663,573 658,896
Commitments and contingencies (Note 17)
Stockholders’ equity    
Preferred stock 100 100
Common stock 10 10
Additional paid-in capital 964,965 892,665
Treasury stock (758,125 shares at December 31, 2025, and March 31, 2025) (71) (71)
Accumulated other comprehensive loss (52,568) (51,304)
Accumulated deficit (717,834) (687,442)
Total stockholders’ equity 194,602 153,958
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 858,175 $ 812,854